Should I buy or sell Alphatec stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ATEC shares. View ATEC analyst ratings or view top-rated stocks .

What is Alphatec's stock price target for 2024?

7 brokers have issued 1-year price objectives for Alphatec's shares. Their ATEC share price targets range from $17.00 to $32.00. On average, they expect the company's stock price to reach $23.63 in the next year. This suggests a possible upside of 88.4% from the stock's current price. View analysts price targets for ATEC or view top-rated stocks among Wall Street analysts .

How have ATEC shares performed in 2024?

Alphatec's stock was trading at $15.11 on January 1st, 2024. Since then, ATEC shares have decreased by 17.0% and is now trading at $12.54. View the best growth stocks for 2024 here .

Are investors shorting Alphatec?

Alphatec saw a increase in short interest in March. As of March 31st, there was short interest totaling 12,360,000 shares, an increase of 12.2% from the March 15th total of 11,020,000 shares. Based on an average trading volume of 1,690,000 shares, the short-interest ratio is presently 7.3 days. View Alphatec's Short Interest .

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our ATEC earnings forecast .

How can I listen to Alphatec's earnings call?

Alphatec will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) posted its quarterly earnings results on Tuesday, February, 27th. The medical technology company reported ($0.37) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by $0.09. The medical technology company had revenue of $138 million for the quarter, compared to analyst estimates of $131.90 million. The company's revenue for the quarter was up 30.3% on a year-over-year basis. During the same period in the prior year, the business posted ($0.33) earnings per share.

What ETFs hold Alphatec's stock?

ETFs with the largest weight of Alphatec (NASDAQ:ATEC) stock in their portfolio include Jacob Forward ETF (JFWD) , Innovator IBD 50 ETF (FFTY) , SPDR S&P Health Care Equipment ETF (XHE) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) . Invesco Nasdaq Future Gen 200 ETF (QQQS) .

What guidance has Alphatec issued on next quarter's earnings?

Alphatec updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $595.0 million-$595.0 million, compared to the consensus revenue estimate of $574.7 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com . Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alphatec investors own include Macrocure Ltd. - Ordinary Share (MCUR) , LinnCo (LNCOQ) , California Resources (CRC) , Sorrento Therapeutics (SRNE) , Catalyst Pharmaceuticals (CPRX) , (GBSN) (GBSN) , Idera Pharmaceuticals (IDRA) , Athersys (ATHX) , Anavex Life Sciences (AVXL) and BioCryst Pharmaceuticals (BCRX) .

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a number of retail and institutional investors. Top institutional investors include Norden Group LLC (0.31%), Congress Asset Management Co. MA (0.10%), Mesirow Financial Investment Management Inc. (0.02%), Insight Folios Inc (0.01%) and Newton One Investments LLC (0.00%). Insiders that own company stock include Craig E Hunsaker , David H Mowry , David M Demski, David R Pelizzon , David Sponsel , Elizabeth Ann Altman, Evan Bakst , James L L Tullis, James L L Tullis , Jason Hochberg , Jennifer N Pritzker, Jennifer N Pritzker , John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles , Paul Segal , Quentin S Blackford, Scott Lish and Tyson Eliot Marshall. View institutional ownership trends .

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ATEC

Alphatec (ATEC) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free ATEC Stock Alerts

$12.54

+0.20 (+1.62%)

(As of 04/19/2024 ET)

Compare

Today's Range: $12.27
▼
$12.79
50-Day Range: $12.34
▼
$16.38
52-Week Range: $8.66
▼
$19.14

Volume: 1.33 million shs
Average Volume: 1.63 million shs
Market Capitalization: $1.73 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $23.63

Get Alphatec alerts:

Alphatec MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 88.4% Upside
$23.63 Price Target
Short Interest: Bearish
8.96% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -1.67
Upright™ Environmental Score
News Sentiment: 1.22
Based on 3 Articles This Week
Insider Trading: Selling Shares
$3.49 M Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.10) to ($0.78) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.11 out of 5 stars

Medical Sector

153rd out of 911 stocks

Surgical & Medical Instruments Industry

23rd out of 97 stocks

3.5

Analyst's Opinion

Consensus Rating
Alphatec has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Alphatec has only been the subject of 4 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
8.96% of the outstanding shares of Alphatec have been sold short.
Short Interest Ratio / Days to Cover
Alphatec has a short interest ratio ("days to cover") of 7.3.
Change versus previous month
Short interest in Alphatec has recently increased by 12.16%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Alphatec does not currently pay a dividend.
Dividend Growth
Alphatec does not have a long track record of dividend growth.

3.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Alphatec has received a 37.18% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Cervical implants", "Medical screws", and "Lumbar spinal stenosis treatment instruments" products. See details.
Environmental Sustainability
The Environmental Impact score for Alphatec is -1.67.

2.3

News and Social Media Coverage

News Sentiment
Alphatec has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Alphatec this week, compared to 3 articles on an average week.
Search Interest
Only 7 people have searched for ATEC on MarketBeat in the last 30 days. This is a decrease of -53% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

5.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Alphatec insiders have sold 659.60% more of their company's stock than they have bought. Specifically, they have bought $459,550.00 in company stock and sold $3,490,745.00 in company stock.
Percentage Held by Insiders
29.12% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
66.35% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Alphatec are expected to grow in the coming year, from ($1.10) to ($0.78) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Alphatec is -8.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Alphatec is -8.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Alphatec has a P/B Ratio of 22.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Alphatec Stock (NASDAQ:ATEC)

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

ATEC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ATEC Stock News Headlines

April 17, 2024 | businesswire.com

ATEC to Report First Quarter Financial Results on May 7, 2024

April 11, 2024 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: ZimVie Inc (ZIMV) and Merus (MRUS)

April 20, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 10, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)

April 4, 2024 | businesswire.com

Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

March 28, 2024 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Alphatec Holdings (ATEC) and Viatris (VTRS)

March 27, 2024 | finance.yahoo.com

Alphatec Holdings, Inc.'s (NASDAQ:ATEC) Intrinsic Value Is Potentially 60% Above Its Share Price

March 25, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC) and Regeneron (REGN)

April 20, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 25, 2024 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Alphatec Holdings (ATEC)

March 21, 2024 | msn.com

5 Stocks Hedge Funds Love and Analysts Support

March 20, 2024 | markets.businessinsider.com

Alphatec Holdings: Poised for Profitable Growth with Billion-Dollar Revenue Target by 2027

March 20, 2024 | markets.businessinsider.com

Buy Rating Affirmed on Alphatec Holdings Amid Strong Growth and Profitability Targets

March 20, 2024 | investorplace.com

Shhh! 7 Small-Cap Stocks That Can Double by 2025

March 15, 2024 | markets.businessinsider.com

Stifel Nicolaus Reaffirms Their Buy Rating on Alphatec Holdings (ATEC)

March 13, 2024 | markets.businessinsider.com

A Closer Look at 4 Analyst Recommendations For Alphatec Holdings

March 13, 2024 | markets.businessinsider.com

Critical Insights From Alphatec Holdings Analyst Ratings: What You Need To Know

March 10, 2024 | investorplace.com

3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio

March 5, 2024 | finance.yahoo.com

Alphatec Holdings Inc CFO John Koning Sells 121,601 Shares

March 1, 2024 | nasdaq.com

Alphatec Holdings (ATEC) Shares Cross Below 200 DMA

March 1, 2024 | finance.yahoo.com

Insider Sell: EVP of Sales David Sponsel Sells 32,365 Shares of Alphatec Holdings Inc (ATEC)

February 29, 2024 | finance.yahoo.com

Alphatec Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

February 28, 2024 | markets.businessinsider.com

Positive Outlook for Alphatec Holdings Justifies Buy Rating

February 28, 2024 | markets.businessinsider.com

Alphatec Holdings (ATEC): Poised for Continued Growth with Market Share Expansion and Technological Advancements

February 28, 2024 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK), Alphatec Holdings (ATEC) and Masimo (MASI)

February 28, 2024 | markets.businessinsider.com

Alphatec Holdings: A Strong Buy on Consistent Performance and Strategic Market Growth

February 27, 2024 | benzinga.com

Alphatec Holdings: Q4 Earnings Insights

See More Headlines

Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/27/2024
Today: 4/19/2024
Next Earnings (Confirmed): 5/07/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Current Symbol: NASDAQ:ATEC
CUSIP: 02081G10
CIK: 1350653
Web: www.atecspine.com
Phone: (760) 431-9286
Fax: 800-922-1356
Employees: 839
Year Founded: 1990

Price Target and Rating

Average Stock Price Target: $23.63
High Stock Price Target: $32.00
Low Stock Price Target: $17.00
Potential Upside/Downside: +88.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.55)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-186,640,000.00
Net Margins: -38.70%
Pretax Margin: -38.76%
Return on Equity: N/A
Return on Assets: -27.93%

Debt

Debt-to-Equity Ratio: 6.54
Current Ratio: 2.86
Quick Ratio: 1.99

Sales & Book Value

Annual Sales: $482.26 million
Price / Sales: 3.59
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.57 per share
Price / Book: 22.00

Miscellaneous

Outstanding Shares: 137,980,000
Free Float: 97,800,000
Market Cap: $1.73 billion
Optionable: Optionable
Beta: 1.55

Social Links

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Patrick S. Miles (Age 58)
Executive Chairman, CEO & President
Comp: $1.59M
Mr. J. Todd Koning (Age 51)
Executive VP & CFO
Comp: $815.29k
Mr. David P. Sponsel (Age 45)
Executive Vice President of Sales
Comp: $848.19k
Mr. Craig E. Hunsaker (Age 60)
Executive VP of People and Culture
Comp: $909.33k
Mr. Eric Dasso (Age 51)
Executive Vice President of Adjunctive Technologies
Comp: $1M
Mr. Scott Lish (Age 45)
Chief Operating Officer
Mr. Tyson Eliot Marshall (Age 50)
General Counsel & Corporate Secretary
Mr. Ali Shorooghi (Age 38)
Senior Vice President of Marketing
Mr. Jonathan Allen (Age 64)
Executive Vice President of Commercial Operations
Dr. Luiz Pimenta
Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ATEC Stock Analysis - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings or view top-rated stocks.
What is Alphatec's stock price target for 2024?: 7 brokers have issued 1-year price objectives for Alphatec's shares. Their ATEC share price targets range from $17.00 to $32.00. On average, they expect the company's stock price to reach $23.63 in the next year. This suggests a possible upside of 88.4% from the stock's current price.
View analysts price targets for ATEC or view top-rated stocks among Wall Street analysts.
How have ATEC shares performed in 2024?: Alphatec's stock was trading at $15.11 on January 1st, 2024. Since then, ATEC shares have decreased by 17.0% and is now trading at $12.54.
View the best growth stocks for 2024 here.
Are investors shorting Alphatec?: Alphatec saw a increase in short interest in March. As of March 31st, there was short interest totaling 12,360,000 shares, an increase of 12.2% from the March 15th total of 11,020,000 shares. Based on an average trading volume of 1,690,000 shares, the short-interest ratio is presently 7.3 days.
View Alphatec's Short Interest.
When is Alphatec's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our ATEC earnings forecast.
How can I listen to Alphatec's earnings call?: Alphatec will be holding an earnings conference call on Tuesday, May 7th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Alphatec's earnings last quarter?: Alphatec Holdings, Inc. (NASDAQ:ATEC) posted its quarterly earnings results on Tuesday, February, 27th. The medical technology company reported ($0.37) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by $0.09. The medical technology company had revenue of $138 million for the quarter, compared to analyst estimates of $131.90 million. The company's revenue for the quarter was up 30.3% on a year-over-year basis. During the same period in the prior year, the business posted ($0.33) earnings per share.

What ETFs hold Alphatec's stock?: ETFs with the largest weight of Alphatec (NASDAQ:ATEC) stock in their portfolio include Jacob Forward ETF (JFWD), Innovator IBD 50 ETF (FFTY), SPDR S&P Health Care Equipment ETF (XHE) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).Invesco Nasdaq Future Gen 200 ETF (QQQS).
What guidance has Alphatec issued on next quarter's earnings?: Alphatec updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $595.0 million-$595.0 million, compared to the consensus revenue estimate of $574.7 million.
What is Pat Miles' approval rating as Alphatec's CEO?: 19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.
What other stocks do shareholders of Alphatec own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alphatec investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), Sorrento Therapeutics (SRNE), Catalyst Pharmaceuticals (CPRX), (GBSN) (GBSN), Idera Pharmaceuticals (IDRA), Athersys (ATHX), Anavex Life Sciences (AVXL) and BioCryst Pharmaceuticals (BCRX).
Who are Alphatec's major shareholders?: Alphatec's stock is owned by a number of retail and institutional investors. Top institutional investors include Norden Group LLC (0.31%), Congress Asset Management Co. MA (0.10%), Mesirow Financial Investment Management Inc. (0.02%), Insight Folios Inc (0.01%) and Newton One Investments LLC (0.00%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David M Demski, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal, Quentin S Blackford, Scott Lish and Tyson Eliot Marshall.
View institutional ownership trends.
How do I buy shares of Alphatec?: Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATEC) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alphatec (ATEC) Stock Price, News & Analysis

Alphatec MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Alphatec Stock (NASDAQ:ATEC)

ATEC Stock Price History

ATEC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

ATEC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™